Background: Due to the lack of consensus on its definition, the metabolic syndrome (MS) in children and adolescents is not formally recognized. However, several researchers have changed the adult criteria for pediatric standards in order to assess the prevalence. Objective: The aim of this study was to evaluate the frequency of MS and its components according to two of the currently used definitions in overweight and obese adolescents. Methods: A cross-sectional study with 232 adolescents with excess weight from a public school of the city of Rio de Janeiro. Anthropometric, blood pressure, and biochemical variables were assessed. MS was defined using two different diagnostic criteria: the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) and International Diabetes Federation (IDF). Results: MS was diagnosed in 40.4 and 24.6% of obese adolescents and 9.4 and 1.9% of overweight adolescents according to the NCEP-ATPIII and IDF criteria, respectively. The degree of agreement, assessed by the κ index, from the definitions adopted in this study was 0.48. Conclusion: The results show a significant difference between the two diagnostic criteria. A higher frequency was found when the NCEP-ATPIII was used, which is of concern given the association of MS with diabetes and cardiovascular disease.

1.
Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F: High prevalence of the metabolic syndrome in Iranian adolescents. Obesity 2006;14:377-382.
2.
Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-2374.
3.
Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM: Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. Am J Clin Nutr 1998;67:1141-1146.
4.
Freedman DS, Dietz WH, Srinivasan SR, Berenson GS: The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999;103:1175-1182.
5.
Katzmarzyk PT, Srinivasan SR, Chen W, Malina RM, Bouchard C, Berenson GS: Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents. Pediatrics 2004;114:198-205.
6.
Lambert M, Paradis G, O'Loughlin J, Delvin EE, Hanley JA, Levy E: Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes 2004;28:833-841.
7.
Cook S, Weitzman M, Auinger P, et al: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-827.
8.
Duncan GE, Li SM, Zhou X: Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999-2000. Diabetes Care 2004;27:2438-2443.
9.
Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N: Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004;110:2494-2497.
10.
Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM: Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 2004;145:445-451.
11.
Ford ES, Li C: Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr 2008;152:160-164.
12.
Alberti KG, Zimmet PZ, Shaw JE: The metabolic syndrome: a new worldwide definition from the International Diabetes Federation Consensus. Lancet 2005;366:1059-1062.
13.
Agirbasli M, Cakir S, Ozme S, Ciliv G: Metabolic syndrome in Turkish children and adolescents. Metabolism 2006;55:1002-1006.
14.
Sartorio A, Agosti F, De Col A, Mornati D, Francescato MP: Prevalence of the metabolic syndrome in Caucasian obese children and adolescents: comparison between three different definition criteria. Diabetes Res Clin Pract 2007;77:341-342.
15.
Flouris AD, Bouziotas C, Christodoulos AD, Koutedakis Y: Longitudinal preventive-screening cutoffs for metabolic syndrome in adolescents. Int J Obes (Lond) 2008;32:1506-1512.
16.
Atabek ME, Pirgon O, Kurtoglu S: Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diabetes Res Clin Pract 2006;72:315-321.
17.
Cook S, Auinger P, Li C, et al: Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr 2008;152:165-170.
18.
Hirschler V, Aranda C, de Lujan Calcagno M, et al: Can waist circumference identify children with the metabolic syndrome? Arch Pediatr Adolesc Med 2005;159:740-744.
19.
Isomaa B, Almgren P, Tuomi T, et al: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
20.
Lee S, Bacha F, Gugor N, et al: Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr 2008;152:177-184.
21.
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J: Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660-667.
22.
Associação Brasileira de Empresas de Pesquisa (ABEP). Critério de classificação econômica Brasil. www.abep.org/codigosguias/ABEP_CCEB_2003.pdf (accessed February 6, 2006).
23.
Guedes DP, Lopes CC, Guedes JE: Reprodutibilidade e validade do Questionário Internacional de Atividade Física em adolescentes. Rev Bras Med Esporte 2005;11:151-158.
24.
Lohman TG, Roche AF, Martorrel R: Anthropometric Standardization Reference Manual. Champaign, Human Kinetics Books, 1988.
25.
Callaway CW, Chumlea WC, Bouchard C, Himes JH, Lohman TG, Martin AD, et al: Circumferences; in Lohman TG, Roche AF, Martorell R: Anthropometric Standardization Reference Manual. Champaign, Human Kinetics Books, 1988, pp 39-54.
26.
Fernández JR, Redden DT, Pietrobelli A, Allison DB: Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004;145:439-444.
27.
Roemmich JN, Clark PA, Lusk M, Friel A, Weltman A, Epstein LH, Rogol AD: Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release. Int J Obes 2002;26:701-709.
28.
Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
29.
Weiss R, Kaufman FR: Metabolic complications of childhood obesity: identifying and mitigating the risk. Diabetes Care 2008;31:310-316.
30.
Holterman MJ, Le Holterman AX, Browne AF: Pediatric obesity. Surg Clin North Am 2012;92:559-582.
31.
Braga-Tavares H, Fonseca H: Prevalence of metabolic syndrome in a Portuguese obese adolescent population according to three different definitions. Eur J Pediatr 2010;169:935-940.
32.
Nasreddine L, Naja F, Tabet M, Habbal MZ, El-Aily A, Haikal C, Sidani S, Adra N, Hwalla N: Obesity is associated with insulin resistance and components of the metabolic syndrome in Lebanese adolescents. Ann Hum Biol 2012;39:122-128.
33.
Sen Y, Kandemir N, Alikasifoglu A, Gonc N, Ozon A: Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity. Eur J Pediatr 2008;167:1183-1189.
34.
Sun SS, Liang R, Huang TT, Daniels SR, Arslanian S, Liu K, et al: Childhood obesity predicts adult metabolic syndrome: the Fels longitudinal study. J Pediatr 2008;152:191-200.
35.
Gang H, Qiao Q, Tuomilehto J, Balkau B, Borchjohnsen K, Pyorala K; DECODE Study Group: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men in women. Arch Intern Med 2004;164:1066-1076.
36.
Morrison JA, Friedman LA, Gray-McGuire C: Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. Pediatrics 2007;120:340-345.
37.
Burrows R, Leiva L, Weistaub G, Ceballos X, Gattas V, Lera L, et al: Prevalence of metabolic syndrome in a sample of Chilean children consulting in an obesity clinic. Rev Med Chil 2007;135:174-181.
38.
Kim HM, Park J, Kim HS, Kim DH: Prevalence of the metabolic syndrome in Korean adolescents aged 12-19 years from the Korean National Health and Nutrition Examination Survey 1998 and 2001. Diabetes Res Clin Pract 2007;75:111-114.
39.
Calcaterra V, Klesy C, Muratori T, Telli S, Caramagna C, Scaglia F, Cistermino M, Larizza D: Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf) 2008;68:868-872.
40.
Stabelini Neto A, Bozza R, Ulbrich A, Mascarenhas LP, Boguszewski MC, Campos WD: Síndrome metabólica em adolescentes de diferentes estados nutricionais. Arq Bras Endocrinol Metab 2012;56:104-109.
41.
Guimarães ICB, Almeida AM, Guimarães AC: Metabolic syndrome in Brazilian adolescents. Diabetes Care 2008;31:4.
42.
Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ: Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004;113:475-482.
43.
Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB: Waist circumference and obesity-associated risk factors among whites in the Third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 2002;76:743-749.
44.
Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S: Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-810.
45.
Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J: The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart 2007;28:857-864.
46.
Goodman E, Daniels SR, Meigs JB, Dolan LM: Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 2007;115:2316-2322.
47.
Ronnemaa T, Knip M, Lautala P, Viikari J, Uhari M, Leino A, et al: Serum insulin and other cardiovascular risk indicators in children, adolescents and young adults. Ann Med 1991;23:67-72.
48.
Sociedade Brasileira de Cardiologia (SBC): I Diretriz de Prevenção da Aterosclerose na Infância e na Adolescência. Arq Bras Cardiol 2005;85:1-36.
49.
Hansen ML, Gunn PW, Kaelber DC: Underdiagnosis of hypertension in children and adolescents. JAMA 2007;298:874-879.
50.
Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005;365:1415-1428.
51.
Dhuper S, Cohen HW, Daniel J, Gumidyala P, Agarwalla V, St Victor R, Dhuper S: Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovasc Diabetol 2007;6:4.
52.
Steinberg J: Diagnosis of metabolic syndrome in children. Curr Opin Lipidol 2003;14:555-559.
53.
Fernández-Real JM, Ricart W: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Rev 2003;24:278-301.
54.
Huang R, Mori TA, Burke V, Newnham J, Stanley FJ, Landau LI, et al: Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents. Diabetes Care 2009;32:695-701.
55.
Rubin DA, McMurray RG, Harrell JS, Hackney AC, Thorpe DE, Haqq AM: The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise. Metabolism 2008;57:683-690.
56.
Ijzerman RG, Voordouw JJ, Van Weissenbrunch MM, Yudkin JS, Serné EH, Delemarre-van de Wal HA, Stehouwer CD: TNF-alpha levels are associated with skin capillary recruitment in humans: a potential explanation for the relationship between TNF-alpha and insulin resistance. Clin Sci 2006;110:361-368.
57.
Srinivasan SR, Myers L, Berenson GS: Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 2002;51:204-209.
58.
Raitakari OT, Juonala M, Rönnemaa T, Keltikangas-Järvinen L, Räsänen L, Pietikäinen M, et al: Cohort profile: the Cardiovascular Risk in Young Finns Study. Int J Epidemiol 2008;37:1220-1226.
59.
Reaven GM: The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006;83:1237-1247.
60.
Marshall WA, Tanner JM: Variations in pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.